Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Constructive on resilient SMID-cap compounders while maintaining strict valuation discipline amid rate hikes and energy inflation, selectively initiating longs in $GWRE, $TYL, and $BF-B while exiting thesis-impaired holdings like $BOOT and $WAY.
Full Quick Take
Constructive on resilient SMID-cap compounders while maintaining strict valuation discipline amid rate hikes and energy inflation, selectively initiating longs in $GWRE, $TYL, and $BF-B while exiting thesis-impaired holdings like $BOOT and $WAY.
Tactically trimming extended global technology ETF exposure to redeploy capital into oversold laggards across consumer staples, consumer discretionary, and utilities.
Full Quick Take
Tactically trimming extended global technology ETF exposure to redeploy capital into oversold laggards across consumer staples, consumer discretionary, and utilities.
Driven by adverse market breadth and underperformance in non-AI holdings, while actively trimming net exposure to 72.5% by deploying into new short ideas across consumer, housing, and powersports sectors.
Full Quick Take
Driven by adverse market breadth and underperformance in non-AI holdings, while actively trimming net exposure to 72.5% by deploying into new short ideas across consumer, housing, and powersports sectors.
On-the-ground UK research increased conviction in Nick Scali (32% like-for-like growth, 60+ store potential) and Lovisa (benefiting from Claire's 590-store closure).
Full Quick Take
On-the-ground UK research increased conviction in Nick Scali (32% like-for-like growth, 60+ store potential) and Lovisa (benefiting from Claire's 590-store closure).
Rebounding from Q1 losses by diversifying into 16 positions across healthcare, biotech, and consumer sectors while aggressively shorting overvalued names.
Full Quick Take
Rebounding from Q1 losses by diversifying into 16 positions across healthcare, biotech, and consumer sectors while aggressively shorting overvalued names.
The concentrated fund maintains three core positions - Lendlease, Baby Bunting, and Ingenia - while holding $100 million cash to capitalize on market dislocations. Long-term focus on unlocking trapped value through active engagement continues despite near-term volatility.
Full Quick Take
The concentrated fund maintains three core positions - Lendlease, Baby Bunting, and Ingenia - while holding $100 million cash to capitalize on market dislocations. Long-term focus on unlocking trapped value through active engagement continues despite near-term volatility.
Facing elevated valuations and a severe global energy supply shock, the manager has raised cash to 20% and restricted consumer exposure. The fund maintains a disciplined, price-sensitive stance, recently exiting Shift4 Payments while avoiding richly priced AI hype.
Full Quick Take
Facing elevated valuations and a severe global energy supply shock, the manager has raised cash to 20% and restricted consumer exposure. The fund maintains a disciplined, price-sensitive stance, recently exiting Shift4 Payments while avoiding richly priced AI hype.
Polaris delivered substantial outperformance in 2025, capitalizing on a pivotal shift from overpriced U.S. tech giants to attractively valued international equities and core AI hardware suppliers.
Full Quick Take
Polaris delivered substantial outperformance in 2025, capitalizing on a pivotal shift from overpriced U.S. tech giants to attractively valued international equities and core AI hardware suppliers.
Lagging its benchmark due to a high-quality underweight in unprofitable health care and material names, but it capitalized on strong tech selection and tactical value swaps like buying Arrow Electronics and adding to Evertec.
Full Quick Take
Lagging its benchmark due to a high-quality underweight in unprofitable health care and material names, but it capitalized on strong tech selection and tactical value swaps like buying Arrow Electronics and adding to Evertec.
The Strategy achieved strong absolute performance but lagged its benchmark due to underweights in high-momentum growth names, prompting the team to selectively add high-quality compounders during market drawdowns.
Full Quick Take
The Strategy achieved strong absolute performance but lagged its benchmark due to underweights in high-momentum growth names, prompting the team to selectively add high-quality compounders during market drawdowns.
Underperforming the Russell 2000. Strategically, the fund exited Interpublic Group (IPG) over merger integration risks and initiated a 1.5% position in Hayward Holdings (HAYW) on cyclical discretionary weakness.
Full Quick Take
Underperforming the Russell 2000. Strategically, the fund exited Interpublic Group (IPG) over merger integration risks and initiated a 1.5% position in Hayward Holdings (HAYW) on cyclical discretionary weakness.
Baird's small/mid-cap growth strategy underperformed in Q2 as their bias toward profitable, higher-multiple stocks faced headwinds. Consumer discretionary led by Deckers performed well, while technology lagged despite AI enthusiasm.
Full Quick Take
Baird's small/mid-cap growth strategy underperformed in Q2 as their bias toward profitable, higher-multiple stocks faced headwinds. Consumer discretionary led by Deckers performed well, while technology lagged despite AI enthusiasm.